
    
      Bone marrow-derived mesenchymal stem cells have the immunosuppressive effect and secrete a
      variety of cytokines, improve the microenvironment of diabetic patients, targeting insulin
      resistance tissue, ameliorate the metabolic disorder of islet damage, protect and
      regeneration of the islet beta cells; reduce high blood sugar.The purpose of this study is to
      evaluate the safety and effectiveness of autologous bone marrow-derived mesenchymal stem
      cells transplantation in treatment 30 patients with type 2 diabetes mellitus at Vinmec
      International Hospital, Hanoi, Vietnam
    
  